AM

Anil Marotrao Pawar

Active Director Director DIN 10239694
DIN 10239694 First appointment Jul 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value •••• Premium profile

About Anil Marotrao Pawar

Data last updated:

Anil Marotrao Pawar is a Director at Precia Pharma Private Limited (since 2023). The company operates in Pharma. Precia Pharma Private Limited reported revenue of ₹5.77 Cr (FY 2023).

DIN 10239694
Primary Designation Director
Industry Pharma
First Appointment 14 Jul 2023
Oldest Company Age 16 yrs
Largest company Precia Pharma Private Limited · ₹5.77 Cr (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Precia Pharma Private Limited U24233MH2010PTC203201
Director14 Jul 20232010₹5.77 Cr (FY 2023)Active

Board colleagues of Anil Marotrao Pawar

NameDINCompanyDesignation
Sanjay Marotrao Pawar02964301Precia Pharma Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Precia Pharma Private Limited
Premium access

Shareholding and investment profile for Anil Marotrao Pawar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anil Marotrao Pawar

Anil Marotrao Pawar currently holds 1 directorship: Precia Pharma Private Limited (Director, since 14 Jul 2023, revenue ₹5.77 Cr (FY 2023)).

Anil Marotrao Pawar was first appointed on 14 Jul 2023 as Director at Precia Pharma Private Limited.

The current boards of Anil Marotrao Pawar's companies include Sanjay Marotrao Pawar (Precia Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available